A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease
NCT06106022
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG:
Vonoprazan
Sponsor
Phathom Pharmaceuticals, Inc.